Norges Bank’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-416,237
| Closed | -$3.08M | – | 816 |
|
2024
Q4 | $3.08M | Buy |
+416,237
| New | +$3.08M | ﹤0.01% | 1621 |
|
2024
Q3 | – | Sell |
-942,983
| Closed | -$7.56M | – | 841 |
|
2024
Q2 | $7.56M | Sell |
942,983
-149,004
| -14% | -$1.2M | ﹤0.01% | 1465 |
|
2024
Q1 | $16.2M | Sell |
1,091,987
-28,470
| -3% | -$422K | ﹤0.01% | 1319 |
|
2023
Q4 | $9.11M | Hold |
1,120,457
| – | – | ﹤0.01% | 1519 |
|
2023
Q3 | $5.1M | Hold |
1,120,457
| – | – | ﹤0.01% | 1668 |
|
2023
Q2 | $7.89M | Sell |
1,120,457
-1,319,600
| -54% | -$9.29M | ﹤0.01% | 1606 |
|
2023
Q1 | $14.9M | Sell |
2,440,057
-534,800
| -18% | -$3.27M | ﹤0.01% | 1412 |
|
2022
Q4 | $19M | Buy |
2,974,857
+1,578,500
| +113% | +$10.1M | ﹤0.01% | 1296 |
|
2022
Q3 | $13.4M | Buy |
1,396,357
+42,122
| +3% | +$404K | ﹤0.01% | 1418 |
|
2022
Q2 | $15M | Buy |
1,354,235
+496
| +0% | +$5.48K | ﹤0.01% | 1383 |
|
2022
Q1 | $22.5M | Buy |
1,353,739
+52,289
| +4% | +$871K | ﹤0.01% | 1334 |
|
2021
Q4 | $24.8M | Buy |
1,301,450
+63,252
| +5% | +$1.21M | 0.01% | 1357 |
|
2021
Q3 | $30.5M | Buy |
1,238,198
+52,525
| +4% | +$1.3M | 0.01% | 1204 |
|
2021
Q2 | $30.9M | Sell |
1,185,673
-38,743
| -3% | -$1.01M | 0.01% | 1257 |
|
2021
Q1 | $38.8M | Sell |
1,224,416
-248,215
| -17% | -$7.86M | 0.01% | 1121 |
|
2020
Q4 | $68.3M | Sell |
1,472,631
-57,523
| -4% | -$2.67M | 0.02% | 771 |
|
2020
Q3 | $50.4M | Buy |
1,530,154
+80,375
| +6% | +$2.65M | 0.01% | 834 |
|
2020
Q2 | $39.8M | Buy |
1,449,779
+140,800
| +11% | +$3.86M | 0.01% | 984 |
|
2020
Q1 | $39.2M | Hold |
1,308,979
| – | – | 0.01% | 824 |
|
2019
Q4 | $36.2M | Buy |
1,308,979
+701,550
| +115% | +$19.4M | 0.01% | 1119 |
|
2019
Q3 | $11.1M | Buy |
607,429
+587,429
| +2,937% | +$10.7M | ﹤0.01% | 1739 |
|
2019
Q2 | $490K | Hold |
20,000
| – | – | ﹤0.01% | 2058 |
|
2019
Q1 | $190K | Hold |
20,000
| – | – | ﹤0.01% | 2099 |
|
2018
Q4 | $177K | Buy |
+20,000
| New | +$177K | ﹤0.01% | 2103 |
|